These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38787838)

  • 21. Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis.
    Kim AY; Woo W; Yon DK; Lee SW; Yang JW; Kim JH; Park S; Koyanagi A; Kim MS; Lee S; Shin JI; Smith L
    Int J Infect Dis; 2022 Jun; 119():130-139. PubMed ID: 35339716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021.
    MacNeil JR; Su JR; Broder KR; Guh AY; Gargano JW; Wallace M; Hadler SC; Scobie HM; Blain AE; Moulia D; Daley MF; McNally VV; Romero JR; Talbot HK; Lee GM; Bell BP; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(17):651-656. PubMed ID: 33914723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral Venous Thrombosis in Patients With Heparin-Induced Thrombocytopenia a Systematic Review.
    Aguiar de Sousa D; Romoli M; Sánchez Van Kammen M; Heldner MR; Zini A; Coutinho JM; Arnold M; Ferro JM
    Stroke; 2022 Jun; 53(6):1892-1903. PubMed ID: 35240862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study.
    Liao D; Zhou F; Luo L; Xu M; Wang H; Xia J; Gao Y; Cai L; Wang Z; Yin P; Wang Y; Tang L; Deng J; Mei H; Hu Y
    Lancet Haematol; 2020 Sep; 7(9):e671-e678. PubMed ID: 32659214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in Catalonia, Spain.
    Burn E; Roel E; Pistillo A; Fernández-Bertolín S; Aragón M; Raventós B; Reyes C; Verhamme K; Rijnbeek P; Li X; Strauss VY; Prieto-Alhambra D; Duarte-Salles T
    Nat Commun; 2022 Nov; 13(1):7169. PubMed ID: 36418321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic.
    Sánchez van Kammen M; Heldner MR; Brodard J; Scutelnic A; Silvis S; Schroeder V; Kremer Hovinga JA; Middeldorp S; Levi M; Hiltunen S; Lindgren E; Mansour M; Arauz A; Barboza MA; Zuurbier SM; Aguiar de Sousa D; Ferro JM; Fischer U; Field TS; Jood K; Tatlisumak T; Putaala J; Arnold M; Coutinho JM
    JAMA; 2021 Jul; 326(4):332-338. PubMed ID: 34213527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS-CoV-2 vaccination.
    van de Munckhof A; Krzywicka K; Aguiar de Sousa D; Sánchez van Kammen M; Heldner MR; Jood K; Lindgren E; Tatlisumak T; Putaala J; Kremer Hovinga JA; Middeldorp S; Levi M; Arnold M; Ferro JM; Coutinho JM
    Eur J Neurol; 2022 Jan; 29(1):339-344. PubMed ID: 34536256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US.
    Rodriguez EVC; Bouazza FZ; Dauby N; Mullier F; d'Otreppe S; Jissendi Tchofo P; Bartiaux M; Sirjacques C; Roman A; Hermans C; Cliquennois M
    Infection; 2022 Apr; 50(2):531-536. PubMed ID: 34626338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in the United Kingdom.
    Burn E; Li X; Delmestri A; Jones N; Duarte-Salles T; Reyes C; Martinez-Hernandez E; Marti E; Verhamme KMC; Rijnbeek PR; Strauss VY; Prieto-Alhambra D
    Nat Commun; 2022 Nov; 13(1):7167. PubMed ID: 36418291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England.
    Whiteley WN; Ip S; Cooper JA; Bolton T; Keene S; Walker V; Denholm R; Akbari A; Omigie E; Hollings S; Di Angelantonio E; Denaxas S; Wood A; Sterne JAC; Sudlow C;
    PLoS Med; 2022 Feb; 19(2):e1003926. PubMed ID: 35192597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ischemic Stroke and Vaccine-Induced Immune Thrombotic Thrombocytopenia following COVID-19 Vaccine: A Case Report with Systematic Review of the Literature.
    Cascio Rizzo A; Giussani G; Agostoni EC
    Cerebrovasc Dis; 2022; 51(6):722-734. PubMed ID: 35512656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 Vaccine-Associated Thrombosis With Thrombocytopenia Syndrome (TTS): A Systematic Review and Post Hoc Analysis.
    Hafeez MU; Ikram M; Shafiq Z; Sarfraz A; Sarfraz Z; Jaiswal V; Sarfraz M; Chérrez-Ojeda I
    Clin Appl Thromb Hemost; 2021; 27():10760296211048815. PubMed ID: 34698582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatal intracerebral haemorrhage associated with thrombosis with thrombocytopenia syndrome after ChAdOx1-S vaccine.
    Gómez-Roldós A; González-Sánchez M; Vales-Montero M; Vázquez-Alen P; Fernández-Bullido Y; Iglesias-Mohedano AM; Díaz-Otero F; García-Pastor A; Gil-Núñez A
    Rev Neurol; 2022 Oct; 75(7):199-202. PubMed ID: 36169326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral Vein Thrombosis With Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    Siegler JE; Klein P; Yaghi S; Vigilante N; Abdalkader M; Coutinho JM; Abdul Khalek F; Nguyen TN
    Stroke; 2021 Aug; 52(9):3045-3053. PubMed ID: 34304601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No increased incidence of venous thrombosis or pulmonary embolism after SARS-CoV-2 vaccination in Germany.
    Tanislav C; Rosenbauer J; Zingel R; Kostev K
    Public Health; 2022 Jun; 207():14-18. PubMed ID: 35461122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination.
    Iba T; Levy JH
    Trends Cardiovasc Med; 2022 Jul; 32(5):249-256. PubMed ID: 35202800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Background incidence rates of hospitalisations and emergency department visits for thromboembolic and coagulation disorders in Ontario, Canada for COVID-19 vaccine safety assessment: a population-based retrospective observational study.
    Nasreen S; Calzavara AJ; Sundaram ME; MacDonald SE; Righolt CH; Pai M; Field TS; Zhou LW; Wilson SE; Kwong JC
    BMJ Open; 2021 Dec; 11(12):e052019. PubMed ID: 34921078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-Stratified Risk of Cerebral Venous Sinus Thrombosis After SARS-CoV-2 Vaccination.
    Krzywicka K; van de Munckhof A; Sánchez van Kammen M; Heldner MR; Jood K; Lindgren E; Tatlisumak T; Putaala J; Kremer Hovinga JA; Middeldorp S; Levi MM; Cordonnier C; Arnold M; Zwinderman AH; Ferro JM; Coutinho JM; Aguiar de Sousa D
    Neurology; 2022 Feb; 98(7):e759-e768. PubMed ID: 34921101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of AZD1222 and BNT162b2 COVID-19 Vaccination With Thromboembolic and Thrombocytopenic Events in Frontline Personnel : A Retrospective Cohort Study.
    Hviid A; Hansen JV; Thiesson EM; Wohlfahrt J
    Ann Intern Med; 2022 Apr; 175(4):541-546. PubMed ID: 35103482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New presentations and exacerbations of immune thrombocytopenia after coronavirus disease 2019 vaccinations: the Taiwan experience.
    Chou SC; Chang YC; Liao CK; Chen TC; Sun KJ; Huang WH; Wu YF
    Platelets; 2022 May; 33(4):531-535. PubMed ID: 35196955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.